Page last updated: 2024-08-25

nobiletin and paxilline

nobiletin has been researched along with paxilline in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Joung, YH; Kang, DY; Kim, WS; Lee, HK; Park, JH; Park, YM; Song, KD; Sp, N; Yang, YM	1

Other Studies

1 other study(ies) available for nobiletin and paxilline

Article	Year
Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER⁺ Breast Cancer Cells. International journal of molecular sciences, 2017, Apr-30, Volume: 18, Issue:5 Topics: Angiogenesis Inhibitors; Cell Proliferation; Flavones; Focal Adhesion Protein-Tyrosine Kinases; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; Paxillin; Receptors, Estrogen; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor	2017

Article

Year

Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER⁺ Breast Cancer Cells.

International journal of molecular sciences, 2017, Apr-30, Volume: 18, Issue:5

Topics: Angiogenesis Inhibitors; Cell Proliferation; Flavones; Focal Adhesion Protein-Tyrosine Kinases; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; Paxillin; Receptors, Estrogen; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor

2017